What We're Reading | BioPharma Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

HHS puts third Ebola vaccine on the fast-track

New, top-shelf breast cancer drug sales lift Roche above Q3 expectations

Sorry, Pfizer: FDA won't nix black box suicide warning for Chantix

Game on: Amgen sues Sanofi, Regeneron over PCSK9 cholesterol drug patent

Potential Novartis psoriasis blockbuster inches closer to approval

Reach our audience

Related Publications

Don't miss tomorrow's biopharma industry news

What We're Reading: Page 395

Oct 20, 2014

HHS puts third Ebola vaccine on the fast-track

New, top-shelf breast cancer drug sales lift Roche above Q3 expectations

Sorry, Pfizer: FDA won't nix black box suicide warning for Chantix

Game on: Amgen sues Sanofi, Regeneron over PCSK9 cholesterol drug patent

Potential Novartis psoriasis blockbuster inches closer to approval

Oct 17, 2014

Oct 16, 2014

Oct 15, 2014

Oct 14, 2014

Oct 13, 2014

Oct 10, 2014